Literature DB >> 16868931

Analysis of the mRNA expression of the TGF-Beta family in testicular cells and localization of the splice variant TGF-beta2B in testis.

Lutz Konrad1, Georg H Lüers, Elke Völck-Badouin, Marcel M Keilani, Leslie Laible, Gerhard Aumüller, Rainer Hofmann.   

Abstract

The transforming growth factors (TGF)-beta, TGF-beta1, TGF-beta2, and TGF-beta3, and their receptors [TbetaRI, TbetaRII, TbetaRIII (betaglycan)] elicit many functions in the testis, for example, they perturb the blood testis barrier (BTB). Although expression of the ligands and receptors have been investigated, the alternative splice variants are incompletely examined. We therefore have analyzed all ligands, the receptors, and the splice variants TbetaRIB, TbetaRIIB, and TGF-beta2B in testicular cells from rat and mouse. In mouse, the novel transcript variant TGF-beta2B was identified and was found in Leydig cells, spermatogonia, pachytene spermatocytes, and in the apical regions of the Sertoli cells in adult testis. Even though expression of the splice variant TbetaRIB could be shown in mouse and rat, we never found the isoform TbetaRIIB in the rat cell lines studied. Whereas in all testicular cells expression of all TGF-beta ligands could be shown, receptor mRNA expression was slightly more diverse. Furthermore, expression pattern of the splice variants was more heterogeneous, for example, TbetaRIB was not detectable in adult Sertoli cells, primary peritubular cells, and immortalized peritubular cells. The heterogeneous expression of the receptors and especially of the splice variants might provide possible clues for the different functions of the TGF-beta ligands in testicular cells. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868931     DOI: 10.1002/mrd.20399

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  7 in total

Review 1.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

2.  Identification and characterization of canine growth differentiation factor-9 and its splicing variant.

Authors:  Osamu Hashimoto; Ryohei Takagi; Fuminari Yanuma; Satoru Doi; Junji Shindo; Hideki Endo; Yoshihisa Hasegawa; Shunichi Shimasaki
Journal:  Gene       Date:  2012-03-15       Impact factor: 3.688

Review 3.  The stem cell identity of testicular cancer.

Authors:  Amander T Clark
Journal:  Stem Cell Rev       Date:  2007-01       Impact factor: 5.739

4.  Altered testicular development as a consequence of increase number of sertoli cell in male lambs exposed prenatally to excess testosterone.

Authors:  Pedro P Rojas-García; Mónica P Recabarren; Teresa Sir-Petermann; Rodolfo Rey; Sergio Palma; Albert Carrasco; Carlos C Perez-Marin; Vasantha Padmanabhan; Sergio E Recabarren
Journal:  Endocrine       Date:  2012-10-18       Impact factor: 3.633

5.  Transforming growth factor beta (TGFbeta1, TGFbeta2 and TGFbeta3) null-mutant phenotypes in embryonic gonadal development.

Authors:  Mushtaq A Memon; Matthew D Anway; Trevor R Covert; Mehmet Uzumcu; Michael K Skinner
Journal:  Mol Cell Endocrinol       Date:  2008-08-26       Impact factor: 4.102

6.  Cre-mediated stress affects sirtuin expression levels, peroxisome biogenesis and metabolism, antioxidant and proinflammatory signaling pathways.

Authors:  Yu Xiao; Srikanth Karnati; Guofeng Qian; Anca Nenicu; Wei Fan; Svetlin Tchatalbachev; Anita Höland; Hamid Hossain; Florian Guillou; Georg H Lüers; Eveline Baumgart-Vogt
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

7.  Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.

Authors:  Lutz Konrad; Jonas A Scheiber; Elke Völck-Badouin; Marcel M Keilani; Leslie Laible; Heidrun Brandt; Ansgar Schmidt; Gerhard Aumüller; Rainer Hofmann
Journal:  BMC Genomics       Date:  2007-09-11       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.